[{"NetIncomeLoss_1_Q1_USD":-16999000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":25300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":12415000.0,"Depreciation_1_Q1_USD":603000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":47407000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":44000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":4000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2572000.0,"AssetsCurrent_0_Q1_USD":146987000.0,"TreasuryStockShares_0_Q1_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4290002.0,"CapitalLeaseObligationsCurrent_0_Q1_USD":4000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2497000.0,"CommonStockSharesIssued_0_Q1_shares":32677454.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":43111000.0,"Assets_0_Q1_USD":156476000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-2000.0,"ShareBasedCompensation_1_Q1_USD":2073000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":93000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-4000.0,"RepaymentsOfLongTermCapitalLeaseObligations_1_Q1_USD":13000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":13100000.0,"UnbilledReceivablesCurrent_0_Q1_USD":532000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16334000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":18883000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-4258000.0,"CommonStockValue_0_Q1_USD":33000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":47504000.0,"ImpairmentOfInvestments_1_Q1_USD":0.0,"DeferredRevenueNoncurrent_0_Q1_USD":1494000.0,"OtherAssetsCurrent_0_Q1_USD":258000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-17001000.0,"OtherAssetsNoncurrent_0_Q1_USD":563000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":100745000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":366344000.0,"Liabilities_0_Q1_USD":28722000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-2000.0,"Dividends_22_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5498000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":31510.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":920000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1775000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_1_Q1_USD":-2000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1466000.0,"CommonStockSharesOutstanding_0_Q1_shares":32594436.0,"RestrictedCashNoncurrent_0_Q1_USD":1092000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":2997000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":6721000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2073000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16226000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q1_USD":93000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":2424000.0,"LiabilitiesCurrent_0_Q1_USD":22631000.0,"DeferredRevenueCurrent_0_Q1_USD":12129000.0,"AccountsPayableCurrent_0_Q1_USD":4797000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2599000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":100745000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-15000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":101837000.0,"InterestReceivable_0_Q1_USD":102000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":40000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7834000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":43693000.0,"MarketableSecurities_0_Q1_USD":43111000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-238619000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-17043000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":156476000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1152000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q1_USD":1000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":14555000.0,"OperatingExpenses_1_Q1_USD":21832000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":2649000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-2016000.0,"ProfitLoss_1_Q1_USD":-16999000.0,"OtherLiabilitiesCurrent_0_Q1_USD":28000.0,"StockholdersEquity_0_Q1_USD":127754000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":262000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":43115000.0,"LeaseIncentivePayableCurrent_0_Q1_USD":469000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-74000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":1663000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":4789000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.54,"AccruedProfessionalFeesCurrent_0_Q1_USD":330000.0,"Ticker":"FULC","CIK":"1680581","name":"FULCRUM THERAPEUTICS, INC.","OfficialName":"Fulcrum Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"518124504.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]